Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: Reversal by means of endothelin antagonism

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 6, 2002, Pages 1114-1119

  Verma, Subodh ^a   Maitland, Andrew ^b   Weisel, Richard D ^a   Fedak, Paul W M ^a   Li, Shu Hong ^a   Mickle, Donald A G ^a   Li, Ren Ke ^a   Ko, Lawrence ^a   Rao, Vivek ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR AGONIST; NITRIC OXIDE; SUBSTANCE P;

ADULT; AGE; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOPLEGIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; VASODILATATION;

EID: 0036622136     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.121972     Document Type: Article

References (32)

1. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000;36:355-65.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12-year cardiovascular mortality from men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-44.
3. Wingard DL, Barett-Connor E. Heart disease ad diabetes. In: National Diabetes Data Group. Diabetes in America. 2nd ed. Washington, DC: Government Printing Office; 1995. p. 429-48. NIH publication no. 95-1468.
4. Kannel W. Lipids, diabetes and coronary heart disease: insights from the Framingham Study. Am Heart J. 1985;110:1100-7.
5. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-44.
6. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, Wilcox RG, et al. for the GUSTO-I investigators. Influence of diabetes mellitus on the clinical outcome in the thrombolytic era of acute myocardial infarction. J Am Coll Cardiol. 1997;30:171-9.
7. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol. 1996; 28:1661-9.
8. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: data from GISS1-2 study. J Am Coll Cardiol. 1993;22:1788-94.
9. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, et al. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1991;84(suppl 3):111275-84.
10. Smith LR, Harell FE Jr, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation. 1991:84(suppl III):III245-53.
11. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED. et al. Five-year angiographic follow up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). The CASS Participating Investigators and Staff. J Am Coll Cardiol. 1993;22:1141-54.
12. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, Karlsson T, et al. Mortality and morbidity in diabetic and non-diabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care. 1996;19:698-703.
13. Barsness GW, Peterson ED, Ohman EM. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 1997;96:2551-6.
14. Andersen B, Goldsmith GH, Spagnolo PJ. Neutrophil adhesive dysfunction in diabetes mellitus: the role of cellular and plasma factors. J Lab Clin Med. 1988;111:275-85.
15. McDonagh P, Hokoma JY. Microvascular perfusion and transport in the diabetic heart. Microcirculation. 2000:7:163-81.
16. Hearse DJ, Stewart DA, Chain EB. Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol. 1975;7:397-415.
17. Kusama Y, Hearse DJ, Avkiran M. Diabetes and susceptibility to reperfusion induced ventricular arrhythmias. J Mol Cell Cardiol. 1992;24:411-21.
18. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg. 1996;112:38-51.
19. Fogelson BG, Nawas SI, Vigneswaran WT, Ferguson JL, Law WR, Sharma AC. Diabetic patients produce an increase in coronary sinus endothelin-1 after coronary artery bypass grafting. Diabetes. 1998;47: 1161-3.
20. Sharma AC, Fogelson BG, Nawas SI, Vigneswaran WT, Sam AD 2nd, Alden KJ, et al. Elevated coronary endothelin-1 but not nitric oxide in diabetics during CABG. Ann Thorac Surg. 1999;67:1659-63.
21. Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett. 1990;267:16-8.
22. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes. 2000;49:1239-48.
23. Arikawa E. Verma S, Dumont AS, McNeill JH. Chronic bosentan treatment improves renal artery vascular function in diabetes. J Hypertens. 2001;19:1-10.
24. Verma S. Arikawa E, McNeill JH. Long-term endothelin receptor blockade improves cardiovascular function in diabetes. Am J Hypertens. 2001;14:679-87.
25. Dorman BH, New RB, Bond BR, Mukerjee R, Mukhin YV, McElmurray JH, et al. Myocyte endothelin exposure during cardioplegic arrest exacerbates contractile dysfunction after reperfusion. Anaesth Analg. 2000;90:1080-5.
26. Metais C, Li J, Simons M, Sellke FW. Serotonin induced coronary contraction increases after blood cardioplegia reperfusion. Role of COX-2 expression. Circulation. 1999:100(suppl II):328-34.
27. Bond BR, Dorman BH, Clair MJ, Walker CA, Pinosky ML, Reeves ST, et al. Endothelin-1 during and after cardiopulmonary bypass: association to graft sensitivity and postoperative recovery. J Thorac Cardiovasc Surg. 2001;122:358-64.
28. Joffs C, Walker CA, Hendrick JW, Fary DJ, Almany DK, Davis JN, et al. Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001;122:365-70.
29. Mathieu P, Dupuis J, Carrier M, Cernacek P, Pellerin M, Perrault LP, et al. Pulmonary metabolism of endothelin-1 during on-pump and beating heart coronary artery bypass operations. J Thorac Cardiovasc Surg. 2001:121:1137-42.
30. Walker CA, Baicu SC, Goldberg AT, Widener CE, Fary DJ, Almany DK, et al. Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2000;120:864-71.
31. Dorman BH, Bond BR, Clair MJ, Walker CA, Pinosky ML, Reeves ST, et al. Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery, J Cardiothorac Vasc Anesth. 2000;14:540-5.
32. Ergul A, Joffs C, Walker AC, Spinale FG. Potential role of endothelin receptor antagonists in the setting of cardiopulmonary bypass: relevance to myocardial performance. Heart Failure Rev. 2001;6:287-94.